Stan Smith, Director at MAIA Biotechnology, Inc. (MAIA), bought 200,000 shares at $2.51 ($502K) on 2024-11-01, disclosed to the SEC on 2024-11-04.
Open-market purchase of $502k MAIA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.51 | 100,000 | $251K | 50.0% |
| 2 | $2.51 | 100,000 | $251K | 50.0% |
| Total | $2.51 avg | 200,000 | $502K | 100% |
| Filing → |
| MAIA | BUY | 2025-12-23 | $140K | — | Filing → |
| MAIA | BUY | 2025-12-09 | $11K | — | Filing → |
| MAIA | BUY | 2025-12-01 | $16K | — | Filing → |